Latest Market Positioning News

Blue Star Helium has achieved its first helium production at the Galactica Project, marking a key milestone as it optimizes plant operations and prepares for commercial ramp-up.

Mastermyne Group has extended its exclusive distribution agreement with Jennmar Holdings for critical strata consolidation products by a decade, locking in supply until 2047. This move strengthens its foothold in the Australian underground coal mining sector.

Qoria Limited has reported a record-breaking quarter with annual recurring revenue exceeding US$100 million and a 42% increase in net ARR for Q2 FY2026, reaffirming its strong growth trajectory and FY26 guidance.

Genetic Signatures reported a $3.3 million quarterly revenue with growing international sales and a robust cash position, while preparing for a leadership change.

Summerset Group Holdings delivered a robust FY25 performance, achieving a 26% increase in total settlements driven by strong new sales and strategic expansion in Australia.

Babylon Pump & Power has agreed to sell its non-core Ausblast business for $2.8 million, streamlining operations and boosting capital for its water management and rental services.

Region Group has announced Greg Chubb as its new CEO and Managing Director, effective 9 March 2026, succeeding Anthony Mellowes who will step back from daily operations a day earlier.

Central Petroleum has confirmed its strategic acquisition in the Cooper and Otway Basins is now unconditional, with completion set for 23 January 2026, marking a significant expansion of its asset portfolio.

Jupiter Energy reported steady oil production and US$1.6 million in domestic sales for Q4 2025, while completing integration of its West Zhetybai oilfield into a regional gas utilisation network.

Knosys’ Greenorbit subsidiary has inked a two-year agency deal with UK-based Oak Engage to offer its advanced intranet platform to existing Greenorbit customers, marking a strategic shift in Knosys’ product focus.

Global Health Limited reports a robust 23% increase in customer receipts and an 85% jump in quarterly operating cashflow, as it advances its transition to AI-enabled SaaS platforms targeting profitability by June 2026.

Vitasora Health has completed an A$11 million capital raise, including a cornerstone investment, bolstering its balance sheet to support ambitious growth in the US healthcare market. The company targets cash flow breakeven by the end of FY2026 amid expanding patient programs and new partnerships.